Magnetically Navigated vs. Manually Guided Radiofrequency in Atrioventricular-node-reentry-tachycardia
MAGMA-AVNRT
Randomized Comparison Between Magnetically Navigated vs Manually Guided Radiofrequency in AV-node-reentry-tachycardia
MAGMA-AVNRT
Randomized Comparison Between Magnetically Navigated vs Manually Guided Radiofrequency in AV-node-reentry-tachycardia
Sponsor study identifier
interventional
300
1 country
1
Study Start
April 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2012
Actual (reported)Study Completion
October 2012
Actual (reported)The MAGMA-AVNRT study compares two different methods of handling the ablation catheters for av-node-reentry-tachycardia with regard to x-ray dose, safety and success: manually guided vs magnetically navigated RF-catheter.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2012
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2009
Date type not reportedThis date has not been verified as actual or estimated.
April 3, 2009
Actual (reported)April 6, 2009
Actual (reported)March 2012
Actual (reported)October 2012
Actual (reported)Total x-ray time and dose for patient
electrophysiological examination
X-ray time and dose for physician
electrophysiological study
Safety of ablation (AV-Block, perforation)
end of electrophysiological study
short-term and long-term-success
end of procedure and 6 months after procedure
number of RF-application
procedure
Duration of electrophysiological study (ablation included)
procedure
Treatment with manually guided RF-catheter
Treatment with magnetically navigated RF-catheter.
4mm-tip catheter manually guided vs magneticallly navigated
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University Hospital Bergen
Bergen, 5021, Norway
Gabi Hessling, MD
Deutsches Herzzentrum München
Peter Schuster, MD
University of Bergen
Isabel Deisenhofer, MD
Deutsches Herzzentrum München
First Submitted
April 3, 2009
First Posted
April 6, 2009
Study Start
April 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2012
Actual (reported)Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
Contact the study team to confirm eligibility.
Study Completion
October 2012
Actual (reported)Last Updated
June 27, 2016
Record last verified: 2016-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: